Freedom Broker Upgrades Atara Biotherapeutics (ATRA) to Hold

May 18, 2026 10:27 AM

Freedom Broker analyst Ilya Zubkov upgraded Atara Biotherapeutics (NASDAQ: ATRA) from Sell to Hold with a price target of $10.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found